When GLP-1 drugs may be appropriate for lipoedema With all of the above said, there are circumstances where GLP-1 drugs may be a reasonable consideration for women with lipoedema: When prediabetes or type 2 diabetes is present and not adequately controlled through nutrition alone When chronic stress and cortisol dysregulation are significantly impairing metabolic function and the ability to lose abdominal weight, despite a well-structured nutrition protocol When these decisions are made collaboratively with a medical team that understands lipoedema and is actively monitoring muscle mass, bone health, nutritional status, and mental health In all cases, a low-inflammatory, nutritionally balanced eating approach remains essential alongside the medication: GLP-1 drugs are not a replacement for good nutrition
If in doubt, a hair analysis will confirm whether it really is only a telogen effluvium
Metabolism 44(9) 1231 PMID: 7666800 Vahl (2003) Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans
Together, these finding suggests a potential reciprocal relationship between VIP signaling and CFTR function
Here's the standard titration protocol: Conservative Titration (Recommended) What to Expect at Each Stage 0.5-1mg : Mild appetite suppression, minimal side effects
